We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




MRI Determines Treatment for Fibroids

By HospiMedica staff writers
Posted on 05 Dec 2005
A study comprised of 100 women suffering from uterine fibroids demonstrated that magnetic resonance imaging (MRI) improves the patient selection for who should receive non-surgical uterine fibroid embolization (UFE) to destroy their tumors. More...


Uterine fibroids are very common benign growths that develop in the muscular wall of the uterus in up to 40% of women age 35 and older. Research also showed interventional radiologists can use MRI scans to determine if a tumor can be embolized, identify other causes for the symptoms, detect pathology that could prevent a women from having UFE and thereby avoid ineffective treatments.

"Using an MRI rather than ultrasound is like listening to a digital CD rather than a record--the quality is better in every way,” stated interventional radiologist and study author Howard B. Chrisman, M.D., of Northwestern University Feinberg School of Medicine (Chicago, IL, USA). "With an MRI we can clearly delineate the location of each fibroid, determine if it's viable for treatment non-surgically, rule out misdiagnosis, identify which treatments are best suited for each patient and avoid ineffective treatments.”

In the study, 100 consecutive women referred to Northwestern University Feinberg School of Medicine for the treatment of symptomatic uterine fibroids were evaluated. Of these women, 94 underwent MRI scans that revealed 381 leiomyomas (fibroids). Based on their MRI results, 21 patients did not undergo embolization to treat the uterine fibroids. In these cases, interventional radiologist used MR images to determine embolization would not be appropriate for the patient, because of biologic factors such as nonviable tumors (tumors lacking adequate blood flow for an embolization), uterus size, and presence of isolated adenomyosis and endometrial lesions. Sixty-eight patients (72%) underwent uterine fibroid embolization.

UFE, also known as uterine artery embolization, is performed by an interventional radiologist or a surgeon. Interventional radiologists utilize imaging modalities to first determine, visualize, and diagnose the pathology and to map out the procedure, customizing it to the individual patient. Then during the procedure, they image in real-time, literally watching and guiding their catheter inside an artery to the site of the problem. This method allows interventional radiologists to deliver targeted treatments directly to the disease non-surgically.

To perform a UFE, the interventional radiologist makes a small cut in the skin in the groin and inserts a catheter into the femoral artery. Using real-time imaging, the radiologist guides the catheter through the artery and then releases tiny particles into the uterine arteries that supply blood to the fibroid tumor. This blocks the blood flow to the fibroid tumor causing it to shrink and die.




Related Links:
Northwestern University Feinberg School of Medicine

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.